The relationship between a firm’s patent quality and its market value — The case of US pharmaceutical industry
-
Federal Circuit Finds That FDA Citizen Petition Could Give Rise To Antitrust Liability – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 7 AUGUST 2014POSTED IN ANTITRUST;FDA;FEDERAL CIRCUIT DECISIONSIn Tyco Healthcare Group LP v. Mutual Pharmaceutical Co., Inc., the...
-
Activists Urge Lawmakers to Prioritize Patients Over Patents – Courtesy(Jakarta Globe)
Pharma Live, , Intellectual Property Rights, 0
Jakarta. Public health activists have called on the government to review a number of key points included in a revised...
-
Federal Circuit Finds No Direct Infringement Of Akamai Patents – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 19 MAY 2015POSTED IN FEDERAL CIRCUIT DECISIONS;INFRINGEMENTThe Federal Circuit issued its remand decision in Akamai Technologies, Inc....
-
FDA Announces Major Proposed Rule Amending Hatch-Waxman Regulations – Courtesy (Hogan Lovells)
Pharma Live, , Intellectual Property Rights, 0
On February 6, 2015, the Food and Drug Administration (FDA) published in the Federal Register (FR) a comprehensive proposed...
-
Patents Against People: How Drug Companies Price Patients out of Survival – Courtesy (Dissent)
Pharma Live, , Intellectual Property Rights, 0
As our television screens toggle between pundits squabbling over Obamacare’s insurance rules and ads for erectile dysfunction remedies, another...
-
Priority setting for orphan drugs: An international comparison
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0168851010002691-mainDownload
-
Prepare for the Japanese Patent Opposition System Coming Soon – Courtesy (Global IP Matters)
Pharma Live, , Intellectual Property Rights, 0
The Japanese Patent Act was revised on May 14, 2014 to provide for post-grant oppositions within one year of the rule...
-
Merck scores victory in India patent battle over top diabetes meds! – Courtesy (Fierce Pharma)
Pharma Live, , Intellectual Property Rights, 0
In a potentially promising sign for Western drugmakers, Merck ($MRK) scored a victory in its patent battle with India’s Glenmark...
![](https://ml7mn4k5dnn0.i.optimole.com/w:289/h:289/q:eco/f:best/https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)